SAMIRNA

Live / Registered — Registered and renewed (as of 29 Aug 2026)

What this means for you

Registered since 04 Oct 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Oct 2036: the §8 & §9 renewal).

Record

Serial number
86287682
Registration number
5052167
Mark type
Word mark
Filed
21 May 2014
Published for opposition
19 Jul 2016
Registered
04 Oct 2016
Current term from
04 Oct 2026
Next maintenance filing
§8 & §9 renewal, due by 04 Oct 2036 (grace period to 04 Apr 2037)
Attorney of record
Jun-Hwa Jeong

Goods and services

  • Class 001 — Chemicals: Diagnostic preparations for research use; Reagents for scientific research use; Chemicals for laboratory analyses, other than for medical use, namely, chemicals for use in biotechnological product development; Chemicals for pharmaceutical purposes, namely, for use in the manufacture of drugs and medicines; Chemicals for the manufacture of medical products in the nature of pharmaceutical preparations; Biochemicals, namely, biochemical reagents used for non-medical purposes; Chemical preparations for the manufacture of medical products
  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Biological preparations for the treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Medicated vaccines and serums for treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Capsules sold empty for pharmaceutical purposes for the treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Microspheres containing pharmaceutical preparations, for treating cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Preparations and substances for facilitating delivery of pharmaceutical preparations, namely, drug delivery agent in the form of nanoparticle for transferring siRNA in the cell; Carriers for drug delivery, namely, drug delivery agent in the form of nanoparticle for transferring siRNA in the cell; Peptides for drug delivery, namely, drug delivery agents consisting of peptides attached to drugs that facilitate delivery of pharmaceutical preparations; Pharmaceutical preparations applied pharmaceutical drug delivery system, namely, elixirs for the treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies and a nanoparticle carrier for transferring siRNA in the cell or peptide; Chemical reagents for medical use; Pharmaceutical preparations for drug delivery into cells; Drug delivery formulations, namely, compositions consisting of nanoparticle for transferring siRNA in the cell or peptides; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purpose; Pharmaceutical preparations and substances for facilitating drug delivery in the form of nanoparticle for transferring siRNA in the cell or peptide for use in medical treatment via inhibition of gene expression; Pharmaceutical preparations containing RNA for use in medical treatment via inhibition of gene expression; Pharmaceutical preparations containing DNA for use in medical treatment via inhibition of gene expression
  • Class 010 — Medical apparatus: [ Drug delivery system; Implantable drug syringes for drug delivery devices; Implantable drug delivery pumps for drug delivery devices; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Injection device for pharmaceuticals; Microspheres, namely, unilaminar and bilaminar spherical particles comprising hydrophilic and hydrophobic polymers with diameters in the nanometer range used as a means for drug delivery for treating cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies ]
  • Class 042 — Scientific and technological services: Pharmaceutical products research; Pharmaceutical products development; Research for medical products; Crude medicines research; Research and development of biotechnology for others; Quality control, namely, quality control of target gene expression activity with siRNA; Biotechnology research

Owner

Prosecution history

  • 29 Aug 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
  • 29 Aug 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
  • 29 Aug 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
  • 29 Aug 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 29 Aug 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 07 Jul 2026 — TEAS SECTION 8 & 9 RECEIVED
  • 04 Oct 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
  • 05 Oct 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
  • 05 Oct 2022 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
  • 04 Oct 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 26 Apr 2022 — TEAS SECTION 8 RECEIVED
  • 04 Oct 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 04 Oct 2016 — REGISTERED-PRINCIPAL REGISTER
  • 19 Jul 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 19 Jul 2016 — PUBLISHED FOR OPPOSITION

View this trademark record on Rightsy